Evidence map›Paper›PMID 42553404›Full record

ArticleFrontiers in immunology2026

From tissue to blood: an integrated multi-omics signature identifies fibrogenesis and neutrophil activation as key drivers of ulcerative colitis severity.

E Ozcariz, M Ostaszewski, O Lopata, L Ciglar, A Y F Li Yim, M Pruijt, X Wang, G A Vignolle, F Tran, V Satagopam and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

E Ozcariz *Center for Health and Bioresources, Molecular Diagnostics, AIT Austrian Institute of Technology GmbH, Giefinggasse, Vienna, Austria.
M Ostaszewski *Bioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
O LopataBioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
L CiglarCenter for Health and Bioresources, Molecular Diagnostics, AIT Austrian Institute of Technology GmbH, Giefinggasse, Vienna, Austria.
A Y F Li YimTytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location University of Amsterdam, Amsterdam, Netherlands.
M PruijtDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, Netherlands.
X WangBioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
G A VignolleVatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
F TranInstitute of Clinical Molecular Biology, University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
V SatagopamBioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
G R D'HaensDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, Netherlands.
S SchreiberInstitute of Clinical Molecular Biology, University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
P RosenstielDepartment Internal Medicine I, Kiel University, University Hospital Schleswig Holstein, Kiel, Germany.
C NöhammerCenter for Health and Bioresources, Molecular Diagnostics, AIT Austrian Institute of Technology GmbH, Giefinggasse, Vienna, Austria.
K VierlingerCenter for Health and Bioresources, Molecular Diagnostics, AIT Austrian Institute of Technology GmbH, Giefinggasse, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ulcerative colitis (UC) is an idiopathic chronic inflammatory disease of the colon characterized by severe disease burden and multiple co-morbidities. Currently, the endoscopic Mayo score is considered the gold standard for assessing disease severity in UC. However, the molecular mechanisms underlying severity are still poorly understood. This study aimed to better understand the molecular alterations associated with severity in UC. To achieve this goal, gene expression and DNA methylation were measured in paired blood and colonic tissue samples from UC patients at different severity stages. Methods: Differential gene expression and methyl-ation analyses, as well as integrative multi-omics network analysis including both omics layers and tissues were performed. A hybrid framework combining prior knowledge and text-mining was deployed to contextualize the associations retrieved from the multi-omics network. Results: Our analyses suggested that mild UC was associated with molecular alterations affecting mainly the colon, while severe UC had systemic consequences. Moreover, the combination of the differentially expressed genes and methylated regions found in blood and colonic tissue allowed us to suggest potential associations between them and formulate hypothesis on novel mechanisms associated with different UC severity stages. Discussion: Among them, fibrogenesis, colonic epithelial cell death, and Tuft cell-related processes seemed to be associated with milder disease stages. In contrast, neutrophil-driven innate immune response and complex B cell and CD4 T cell interactions were suggested as potential mechanisms involved in severe UC. Finally, the findings of this study led to the formulation of a hypothesis suggesting that impaired PPARG anti-inflammatory regulation associated with colonic LCN2 activity might play a relevant role in UC severity.

Indexed as

Colitis, UlcerativeNeutrophil ActivationAdultColonDNA MethylationFemaleFibrosisGene Expression ProfilingHumansMaleMiddle AgedMultiomicsNeutrophilsSeverity of Illness IndexTranscriptomeDNA Methylationfibrogenesismulti-omicsneutrophilseveritytranscriptomicsulcerative colitis

Identifiers

PMID42553404
PMCPMC13433763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.